Clous

Ocean Biomedical, Inc.

OTC: OCEA

Pharmaceutical Preparations · Entity-resolved by Clous

CIK0001869974
TickerOCEA
ExchangeOTC
SIC2834
StateDE
FY end12-31

Key financials

Revenue
Net IncomeFY2024-12-31
-$9.48M
+91.7% YoY
Total AssetsFY2024-12-31
$902K
-83.6% YoY
EquityFY2024-12-31
-$97.62M
-7.6% YoY
Shares OutstandingFY2024-12-31
166.01M
Operating Cash FlowFY2024-12-31
-$4.18M
+55.7% YoY

Short interest & fails

Short-sale volume
FINRA Reg SHO · daily
48.0%
short of total volume · 2025-04-23
2025-04-2348.0%
2025-04-2257.0%
2025-04-2145.0%
2025-04-1743.7%
2025-04-1649.6%

Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.

ConceptFY2021-12-31FY2022-12-31FY2023-12-31FY2024-12-31YoY% rev
Net Income-$958.43K-$114.47M-$9.48M+91.7%
Total Assets$108.65M$110.91M$5.5M$902K-83.6%
Equity-$1.84M-$6.15M-$90.76M-$97.62M-7.6%
Operating Cash Flow-$747.3K-$9.43M-$4.18M+55.7%
Shares Outstanding166.01M
Source: SEC EDGAR · resolved by Clous · as of 2026-05-30Warehouse synced 2026-06-20 06:30 UTC

Get this entity — and 970.89K+ others — programmatically.

One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.

GET /v1/entities?cik=0001869974